TITLE

ON THE PREVENTION OF CORONARY OCCLUSION

AUTHOR(S)
Starr, Paul
PUB. DATE
February 1962
SOURCE
Angiology;Feb1962, Vol. 13 Issue 2, p55
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
Reports on the prevention of coronary occlusion upon correcting hypercholesterolemia using different pharmacologic agents. Capacity of nicotinic acid to lower serum cholesterol; Efficacy of triparanol on blocking the last step in the synthesis of cholesterol; Avoidance of animal tissue cholesterol absorption through oral administration of vegetable sterol sitosterol.
ACCESSION #
16371223

 

Related Articles

  • RIGHT CORONARY ARTERY OCCLUSION DURING RETROGRADE LEFT HEART CATHETERIZATION COMPLICATED BY RARE ARRHYTHMIAS. Tsitouris, George; Lekos, Demetrios // Angiology;Dec1965, Vol. 16 Issue 12, p748 

    A case is reported in which the right coronary artery was transiently occluded by the catheter during retrograde catheterization of the left ventricle. ECG changes of myocardial injury appeared for 5 to 7 min., accompanied by S-A block, A-V block and nodal rhythm. The danger of accidental...

  • Split Right Coronary Artery. Sawaya, Fadi J.; Sawaya, Jaber I.; Angelini, Paolo // Texas Heart Institute Journal;2008, Vol. 35 Issue 4, p477 

    We report here, for perhaps the 1st time in the English-language literature, the extent of the territory fed by the anterior bifurcation of the (anomalous) split right coronary artery (RCA). A 64-year-old man presented with an occlusion of the anterior bifurcation of a split RCA--which resulted...

  • Impairment of insulin-stimulated Akt/GLUT4 signaling is associated with cardiac contractile dysfunction and aggravates I/R injury in STZ-diabetic Rats. Jiung-Pang Huang; Shiang-Suo Huang; Jen-Ying Deng; Li- Man Hung // Journal of Biomedical Science;2009, Vol. 16, p1 

    In this study, we established systemic in-vivo evidence from molecular to organism level to explain how diabetes can aggravate myocardial ischemia-reperfusion (I/R) injury and revealed the role of insulin signaling (with specific focus on Akt/GLUT4 signaling molecules). The myocardial I/R injury...

  • Effects of Intracoronary Infusion of Adenosine on Cumulative Deterioration of Regional Myocardial Wall Motion Induced by Repeated Brief Periods of Coronary Occlusion in Anesthetized Dogs. Satani, Arata; Kawashima, Seinosuke; Iwasaki, Tadaaki // Angiology;Aug1994, Vol. 45 Issue 8, p695 

    The present study was performed to evaluate the effects of the intracoronary infusion of adenosine on regional wall motion in the canine heart subjected to repeated brief coronary occlusion and reperfusion. In anesthetized open-chest dogs, six episodes of five-minute coronary occlusion followed...

  • Total Occlusion of the Left Main Coronary Artery. Sohi, Gurbachan S.; Flowers, Nancy C. // Vascular Surgery;Nov/Dec1981, Vol. 15 Issue 6, p409 

    An extremely rare case with total occlusion of the left main coronary artery is described. The role of collaterals from the right coronary artery in the maintenance of adequate left ventricular function and in the patient's survival is discussed. The need for emergency aortocoronary bypass...

  • Ezetimibe/Simvastatin: A Review of its Use in the Management of Hypercholesterolemia. Murdoch, David; Scott, Lesley J. // American Journal of Cardiovascular Drugs;2004, Vol. 4 Issue 6, p405 

    Ezetimibe/simvastatin (Inegyâ„¢, Vytorinâ„¢) therapy combines two lipid-lowering compounds with complementary mechanisms of action, thereby blocking the two sources of plasma cholesterol and improving lipid profiles. Thus, intestinal absorption of dietary cholesterol and related...

  • Long-term effects of policosanol on obese patients with Type II Hypercholesterolemia. Mas, R.; Castaño, G.; Fernández, J.; Gamez, R.; Illnait, J.; Fernandez, L.; Lopez, E.; Mesa, M.; Alvarez, E.; Mendoza, S. // Asia Pacific Journal of Clinical Nutrition;2004 Supplement, Vol. 13, pS102 

    Both hypercholesterolemia (HC) and obesity are coronary risk factors. Clinical studies have shown the benefits of lowering elevated plasma levels of low-density lipoprotein-cholesterol (LDL-C) on clinical end-points. Policosanol is a cholesterol-lowering drug purified from sugar cane wax with a...

  • Prevalence of Cholesterol Treatment Eligibility and Medication Use Among Adults--United States, 2005-2012. Mercado, Carla; DeSimone, Ariadne K.; Odom, Erika; Gillespie, Cathleen; Ayala, Carma; Loustalot, Fleetwood // MMWR: Morbidity & Mortality Weekly Report;12/4/2015, Vol. 64 Issue 47, p1305 

    A high blood level of low-density lipoprotein cholesterol (LDL-C) remains a major risk factor for atherosclerotic cardiovascular disease (ASCVD), although data from 2005 through 2012 has shown a decline in high cholesterol (total and LDL cholesterol) along with an increase in the use of...

  • Dedicated devices and techniques - a cornerstone in recanalisation of chronic total occlusions of coronary arteries. Bryniarski, Leszek; Kusak, Piotr; Surowiec, Sławomir; Dudek, Dariusz; Czarnecka, Danuta // Advances in Interventional Cardiology;2014, Vol. 10 Issue 3, p213 

    Recanalisation of chronic total occlusion (CTO) is still a challenge in invasive cardiology, requiring operator experience, equipment, and techniques dedicated to CTO. Due to difficulties in crossing the lesion by wire and by balloon (both responsible for 98% of the procedure's failures), many...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics